Lovastatin promotes myelin formation in NPC1 mutant oligodendrocytes
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 386, 56-63
Abstract
No abstract availableKeywords
Funding Information
- Chinese Scholarship Council (201206170169, 201306170014)
This publication has 44 references indexed in Scilit:
- The Transcription Factors Sox10 and Myrf Define an Essential Regulatory Network Module in Differentiating OligodendrocytesPLOS Genetics, 2013
- Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS MyelinPLOS Genetics, 2013
- Derivation of Enriched Oligodendrocyte Cultures and Oligodendrocyte/Neuron Myelinating Co-cultures from Post-natal Murine TissuesJournal of Visualized Experiments, 2011
- Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafishJournal of Lipid Research, 2011
- Activation of PPAR‐γ and PTEN cascade participates in lovastatin‐mediated accelerated differentiation of oligodendrocyte progenitor cellsGlia, 2010
- Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelinationExperimental Neurology, 2009
- Distinct Stages of Myelination Regulated by γ-Secretase and Astrocytes in a Rapidly Myelinating CNS Coculture SystemNeuron, 2008
- Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2–dependent RNA granulesJournal of Cell Biology, 2008
- Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune EncephalomyelitisMolecular Pharmacology, 2008
- The dysmyelinating mouse mutations shiverer (shi) and myelin deficient (shi mld )Behavior Genetics, 1990